BMY (bristol myers squibb) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BMY (bristol myers squibb)

BMY 42.82

-1.3%

9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (183)	6/24/2019 5:52:10 PM
From: zax	Read Replies (3) of 194

Fuck. I bought BMY just because of Celgene's Otezla, which is shaping up to be a Remicade-type blockbuster. This is not good. With that forced divestiture news alone, nearly all of the 8 1/2% gain I'd seen in BMY in the past two months evaporated today. Live and learn. I would suppose a lot of others were thinking the same as me. Looks like Celgene took a 5 1/2% hit today on the news, too.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next